4.3 Article

The A2a adenosine receptor modulates the reinforcement efficacy and neurotoxicity of MDMA

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Adenosine A2Areceptors and their role in drug addiction

Robyn M. Brown et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)

Article Biochemistry & Molecular Biology

Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling

David M. Thomas et al.

JOURNAL OF NEUROCHEMISTRY (2008)

Review Critical Care Medicine

Clinical review: Major consequences of illicit drug consumption

Robert J. Devlin et al.

CRITICAL CARE (2008)

Article Neurosciences

Adenosine A2A receptors and basal ganglia physiology

S. N. Schiffmann et al.

PROGRESS IN NEUROBIOLOGY (2007)

Review Neurosciences

Neurotoxicity of substituted amphetamines: Molecular and cellular mechanisms

Jean Lud Cadet et al.

NEUROTOXICITY RESEARCH (2007)

Article Neurosciences

Attenuation of nicotine-induced rewarding effects in A2A knockout mice

Anna Castane et al.

NEUROPHARMACOLOGY (2006)

Article Neurosciences

The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine

G Soria et al.

NEUROPSYCHOPHARMACOLOGY (2006)

Article Neurosciences

A reliable model of intravenous MDMA self-administration in naive mice

JM Trigo et al.

PSYCHOPHARMACOLOGY (2006)

Article Biochemistry & Molecular Biology

Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia

J Saura et al.

JOURNAL OF NEUROCHEMISTRY (2005)

Article Multidisciplinary Sciences

Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors

A Bilkei-Gorzo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Pharmacology & Pharmacy

Adenosine receptor signaling in the brain immune system

G Haskó et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2005)

Article Neurosciences

Lack of CB1 cannabinoid receptor impairs cocaine self-administration

G Soria et al.

NEUROPSYCHOPHARMACOLOGY (2005)

Article Substance Abuse

Ethanol operant self-administration in rats is regulated by adenosine A2 receptors

MP Arolfo et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2004)

Article Neurosciences

Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC

G Soria et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2004)

Article Multidisciplinary Sciences

Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-βγ dimers

LN Yao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Review Pharmacology & Pharmacy

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)

AR Green et al.

PHARMACOLOGICAL REVIEWS (2003)

Article Neurosciences

Association between A2a receptor gene polymorphisms and caffeine-induced anxiety

K Alsene et al.

NEUROPSYCHOPHARMACOLOGY (2003)

Article Behavioral Sciences

Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor

JH Wang et al.

BEHAVIOURAL BRAIN RESEARCH (2003)

Article Pharmacology & Pharmacy

Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice

J Salzmann et al.

BRITISH JOURNAL OF PHARMACOLOGY (2003)

Article Biochemistry & Molecular Biology

Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors

J Hillion et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Pharmacology & Pharmacy

Effects of adenosine agonists on consumptive behaviour and body temperature

IM Coupar et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)

Article Pharmacology & Pharmacy

Reinforcing effects of MDMA ('ecstasy') in drug-naive and cocaine-trained rats

E Ratzenboeck et al.

PHARMACOLOGY (2001)

Article Pharmacology & Pharmacy

Human pharmacology of 3,4-methylenedioxymethamphetamine (ecstasy):: Psychomotor performance and subjective effects

J Camí et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)